Sorted By:


MIT scientists find evidence that Alzheimer’s ‘lost memories’ may one day be recoverable

From Hope To Cures  |  From Our Network

 Nature reported that early trials showed that deep-brain stimulation of the hippocampus may improve memory in some Alzheimer's patients.

Medicare Monday: How existing CMMI models affect Medicare Part B

PhRMA  |  Blog Post

For more information on Medicare Part B, visit

Medicare Monday: New research reveals Part D coverage is more robust than VA coverage for new, innovative medicines

PhRMA  |  Blog Post

The study suggests the implementation of a government price setting in Part D, similar to the VA, could limit access to the latest, most innovative medicines in Part D.

GAO: Prescription Drugs Are Just 2% of Medicaid Spending

PhRMA  |  Blog Post

Statement Regarding GAO Report on Drug Prices

PhRMA  |  Press Release

PhRMA companies are leading the way in the search for new cures.

World AIDS Day: Making progress

PhRMA  |  Blog Post

While medication can help keep HIV from becoming AIDS, one has to first know they are infected which is why it can be surprising that 156,000 of those infected with HIV don’t even know they have it.

Medicare Monday: 3 tips for choosing a Medicare Part D plan

PhRMA  |  Blog Post

Even if you’re happy with your current plan, be sure to see if anything has changed for the coming year to make sure it will still work for you.

Medicare Monday: How government price setting in Part D could reduce innovation, shorten life expectancy for beneficiaries

PhRMA  |  Blog Post

Learn more about Medicare Part D and the importance of ensuring the program continues to provide seniors and individuals with disabilities access to affordable prescription drug coverage.

PhRMA Statement on AARP Prescription Drug Report

PhRMA  |  Press Release

We will continue to be a constructive partner to help pass a comprehensive health care reform bill that can get to the President’s desk this year.”

Medicare Monday: A guide to MedPAC’s Part B vote this week

PhRMA  |  Blog Post

The ASP mechanism has been successful at moderating price growth over time, and even CMS has noted multiple competitive factors are at work to keep prices stable.

Medicare Part D Savings

PhRMA  |  Graphic


New Medicines - the Long Path to Approval

PhRMA  |  Blog Post

Paving the Way for Better Cancer Treatments

PhRMA  |  Blog Post


PhRMA  |  From PhRMA

For 2016, there are, on average, 26 Part D plan choices available in every region.

Part B

PhRMA  |  From PhRMA

Recent research found the volume-weighted average sales price for Part B drugs has remained steady year over year, suggesting that prescription medicines and biologicals are not a key driver of program costs.

Critics Say High Deductibles Make Insurance ‘Unaffordable’

Access Better Coverage  |  From Our Network

The mounting debt has Roger Anderson choosing to forgo the twice-weekly physical therapy prescribed by his doctor — and losing muscle mass as a consequence — because he can’t afford the $200-a-month copay.

Medicare Part D- Extra Help Program

PhRMA  |  Video

Extra Help is a program in Medicare Part D that helps beneficiaries with limited incomes afford their medicines.

New Blood Tests, Liquid Biopsies, May Transform Cancer Care

From Hope To Cures  |  From Our Network

"I spent most of my life giving drugs that were useless to people" because there was no good way to tell who would benefit or quickly tell when one wasn't working, she said.

New Chart Pack: Advancing Innovative Treatment Options for Patients Through Personalized Medicine

PhRMA  |  Blog Post

Biopharmaceutical Sector Leads the Way in Clinical Trial Data Sharing

PhRMA  |  Blog Post

The War on Alzheimer’s: Progress and Challenges of Biopharmaceutical Research

PhRMA  |  Blog Post

While researchers have come a long way, we still have much work to do to understand causes of the disease and how it progresses.

Because One Day Isn't Enough

PhRMA  |  Blog Post

Click here to see some videos that we put together about rare diseases and come back throughout the week to see what else has caught our eyes.

Biopharmaceuticals in Perspective: Chart Pack 2013

PhRMA  |  Report

Topics include medicines’ impact on health and quality of life, the drug discovery and development process, biopharmaceutical spending and costs, the challenge of treatment gaps and improving use of prescribed therapies, the marketing and promotion of medicines, and the role of the biopharmaceutical sector in the U.S. economy.

A new kind of Chart Pack

PhRMA  |  Blog Post

Please share the Chart Pack platform with your network, and stay tuned for updates and additions!

Medicare Monday: New study further confirms increased use of generics after Part D

PhRMA  |  Blog Post

Since its implementation in 2006, the program has continued to ensure that beneficiaries have affordable access to the prescription medicines they need.

You have reviewed the first 150 results out of 2122. Each page contains 25 results. You're on page 6.

prev 1 2 3 4 5 6 next